CME/CE Podcast
Sanjiv S. Agarwala, MD
Chief, Oncology & Hematology
St. Luke’s University Health Network
Professor of Medicine
Temple University
Philadelphia, Pennsylvania
Listen to Dr. Agarwala provide answers on frequently asked questions about biosimilars:
- Where is the US on the “learning curve” with regard to biosimilars?
Listen
- How comfortable are US health care providers with the safety and efficacy data available for biosimilars?
Listen
- Are clinicians drawing on the European experience with biosimilars to inform understanding?
Listen
- What are the challenges ahead for the integration of biosimilars into clinical practice?
Listen
- What is the current status of states legislation related to interchangeability?
Listen
- What are the considerations for P&T committees regarding biosimilars?
Listen
- Can you comment on the importance of patient education related to biosimilars?
Listen
- What new developments related to biosimilars are anticipated in 2016?
Listen